acitretin has been researched along with Lymph Node Metastasis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fenchel, K; Sachse, MM; Wagner, G | 1 |
Armingaud, P; Cambie, MP; Esteve, E; Huet, C; Kalis, B; Maquaire, J; Penouil, MH; Serpier, H | 1 |
2 other study(ies) available for acitretin and Lymph Node Metastasis
Article | Year |
---|---|
Regression of B-RAF inhibitor associated keratoacanthomas by acitretin - how do retinoids act on the RAF/MEK/ERK-signaling pathway?
Topics: Acitretin; Adult; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Eyelid Diseases; Female; Humans; Indoles; Keratoacanthoma; Lung Neoplasms; Lymphatic Metastasis; MAP Kinase Kinase 1; MAP Kinase Signaling System; Melanoma; Neoplasm Staging; Neoplasms, Unknown Primary; Proto-Oncogene Proteins B-raf; Signal Transduction; Sulfonamides; Vemurafenib | 2014 |
[Bazex paraneoplastic acrokeratosis. Treatment with acitretin].
Topics: Acitretin; Acrodermatitis; Aged; Head and Neck Neoplasms; Humans; Keratosis; Lymphatic Metastasis; Male; Paraneoplastic Syndromes; Treatment Outcome | 1995 |